Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC
More than one-third of physicians report not having sufficient information to decide on how to sequence specific targeted lung cancer treatments Survey findings presented today as a late-b......
